Wedge Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q3 | $25.3M | Sell |
|
|||||
2025
Q2 | $31.8M | Sell |
|
|||||
2025
Q1 | $33.7M | Sell |
|
|||||
2024
Q4 | $28.9M | Sell |
|
|||||
2024
Q3 | $33.5M | Buy |
|
|||||
2022
Q1 | – | Sell |
|
|||||
2021
Q4 | $35.7M | Buy |
|
|||||
2021
Q3 | $30.6M | Sell |
|
|||||
2021
Q2 | $32.6M | Sell |
|
|||||
2021
Q1 | $31.2M | Buy |
|
|||||
2020
Q4 | – | Sell |
|
|||||
2020
Q3 | $26.8M | Sell |
|
|||||
2020
Q2 | $34.3M | Buy |
|
|||||
2020
Q1 | – | Sell |
|
|||||
2019
Q4 | $42.5M | Buy |
|
|||||
2019
Q3 | $32.6M | Buy |
|
|||||
2019
Q2 | $34.4M | Sell |
|
|||||
2019
Q1 | $39.3M | Buy |
|
|||||
2018
Q4 | $31M | Buy |
|
|||||
2018
Q3 | $36.6M | Buy |
|
|||||
2017
Q4 | – | Sell |
|
|||||
2017
Q3 | $43.4M | Buy |
|
|||||
2016
Q3 | – | Sell |
|
|||||
2016
Q2 | $47.8M | Buy |
|
|||||
2016
Q1 | $40.5M | Buy |
|